Neil Carragher
Presidente en The Corporate Partnership Ltd. .
Perfil
Neil Carragher is the founder of Pheno Therapeutics Ltd.
which was founded in 2018.
He is currently the Chairman of The Corporate Partnership Ltd.
Mr. Carragher's former positions include Chairman of NUCRYST Pharmaceuticals Corp.
from 2005 to 2010, and Director positions at Agrium, Inc. and The Westaim Corp.
Mr. Carragher's education includes an undergraduate degree from the University of Glasgow and a graduate degree from the University of London.
Cargos activos de Neil Carragher
| Empresas | Cargo | Inicio |
|---|---|---|
| The Corporate Partnership Ltd. | Presidente | - |
Antiguos cargos conocidos de Neil Carragher.
| Empresas | Cargo | Fin |
|---|---|---|
NUCRYST Pharmaceuticals Corp.
 NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | Presidente | 09/02/2010 |
Pheno Therapeutics Ltd.
 Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | Fundador | - |
| THE WESTAIM CORPORATION | Director/Miembro de la Junta | - |
| AGRIUM INC | Director/Miembro de la Junta | - |
Formación de Neil Carragher.
| University of Glasgow | Undergraduate Degree |
| University of London | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| THE WESTAIM CORPORATION | Finance |
| Empresas privadas | 4 |
|---|---|
Agrium, Inc.
 Agrium, Inc. Chemicals: AgriculturalProcess Industries Agrium, Inc. engages in the production and distribution of agricultural products, services, and solutions. It operates through the Retail and Wholesale segments. The Retail segment offers crop nutrients, crop protection products, seed, merchandise and services. The Wholesale segment produces, markets, and distributes crop nutrients and industrial products. The company was founded on December 21, 1992 and is headquartered in Calgary, Canada | Process Industries |
| The Corporate Partnership Ltd. | |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | Health Technology |
Pheno Therapeutics Ltd.
Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
- Bolsa de valores
- Insiders
- Neil Carragher
